Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
May help promote an improvement in physical performance when used in conjunction with a training regimen
Lilly is evaluating next steps in the study of GIP/GLP-1 RA for obesity and other conditions
"Lilly's phase 2 retatrutide results published in The New England Journal of Medicine show the investigational molecule achieved up to 17.5% mean weight reduction at 24 weeks in adults with obesity and overweight"
Age and health status influence decision making
US$ 26.25
US$ 27.00
US$ 21.98
US$ 21.23
US$ 27.04
US$ 22.38
US$ 20.18
US$ 20.76
US$ 26.98
US$ 24.59
US$ 29.55
